期刊文献+

中、低危心房纤颤患者使用阿司匹林抗栓治疗的疗效观察 被引量:1

下载PDF
导出
摘要 目的:探讨中、低危心房纤颤患者使用阿司匹林抗栓治疗的临床疗效。方法:收治中、低危心房纤颤患者54例,随机分为对照组和观察组,每组27例,对照组予通心络胶囊,2粒/次,3次/日口服;观察组在对照组的基础上加用阿司匹林100mg,1粒/晚口服。两组均每个月随访1次,共6次。结果:两组治疗前后TC、TG、HDL-C比较有显著性差异(P<0.05),但是组间比较无显著性差异(P>0.05)。两组患者纤维蛋白原、红细胞刚性指数、红细胞聚集指数、高切还原黏度、毛细血管血浆黏度、高切全血黏度、低切还原黏度、血沉方程K值、低切全血黏度,比较有显著性差异(P<0.05),血沉、红细胞压积比较无显著性差异(P>0.05)。
作者 谢干平
出处 《中国社区医师(医学专业)》 2012年第11期67-67,共1页
  • 相关文献

参考文献2

二级参考文献33

  • 1胡大一,周自强,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状流行病学研究[J].中国心脏起搏与心电生理杂志,2004(z1):3-6. 被引量:32
  • 2Olsson SB, Executive Steering Committee of the SPORTIF Ⅲ Investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non - valvular atrial fibrillation (SPORTIF Ⅲ): randomised controlled trial. Lancet ,2003,362 : 1691-1698. 被引量:1
  • 3Albers GW, Diener HC, FrisonL, et al. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvularalrial fibrillation. A randomized triM. JAMA,2005,293:690-698. 被引量:1
  • 4Wallentin L, Ezekowitz M, Simmers TA, et al. PETRO - investigators. Safety and efficacy of a new oral direct thrombin inhibitor dabigatran in atrial fibrillation:a dose finding trial with comparison to warfarin. Eur Heart J, 2005,26:482. 被引量:1
  • 5Van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation-an individual patient meta - analysis. JAMA,2002,288:2441-2448. 被引量:1
  • 6Roberts GW, Gallus AS, Druskeit T, et al. Comparision of an age adjusted warfarin loading protocol with empirical dosing and Fenhetty's protocol. Aust NZ J Med, 1999,29:731-736. 被引量:1
  • 7Eckhoff CD, Didomenico RJ, Shapiro NL. Initiating warfarin therapy: 5 mg versus 10 mg. Ann Pharmacother, 2004, 38: 2115-2121. 被引量:1
  • 8Hirsh J, Fuster V, Ansell J, et al. American heart Association/ American College of Cardiology Foundation. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coil Cardiol, 2003,41:1633-1652. 被引量:1
  • 9Burak P, Huseyin O, Imran O, et al. Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study. Blood Coagul Fibrinolysis, 2007,18(2) :187-192. 被引量:1
  • 10Howard PA. Aspirin resistance. Ann Pharmacother, 2002, 36(100) : 1620-1624. 被引量:1

共引文献10

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部